Skip to main content
SpringerLink
Log in

Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis

  • Case Report
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Billstein SA ,Sudol TE (1988) Ceftriaxone and biliary pseudolithiasis. Pediatr Infect Dis J 7:818–820

    PubMed  CAS  Google Scholar 

  2. Blais C ,Duperval R (1994) Biliary pseudolithiasis in a child associated with 2 days of ceftriaxone therapy. Pediatr Radiol 24:218–219

    Article  PubMed  CAS  Google Scholar 

  3. Bonnet JP, Abid L, Dabhar A, Levy A, Soulier Y ,Blangy S (2000) Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children. Eur J Pediatr Surg 10:368–371

    Article  PubMed  CAS  Google Scholar 

  4. Bor O, Dinleyici EC, Kebapci M ,Aydogdu SD (2004) Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Pediatr Int 46:322–324

    Article  PubMed  Google Scholar 

  5. Brogard JM, Blickle JF, Jehl F, Arnaud JP, Paris-Bockel D ,Monteil H (1988) High biliary elimination of ceftriaxone in man. Int J Clin Pharmacol Ther Toxicol 26:167–172

    PubMed  CAS  Google Scholar 

  6. Brogden RN ,Spencer CM (1997) Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections. Drugs 53:483–510

    PubMed  CAS  Google Scholar 

  7. Guggenbichler JP, Kofler J ,Allerberger F (1985) The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection 13(Suppl 1):S137–S139

    Article  PubMed  Google Scholar 

  8. Hayton W ,Stoeckel K (1986) Biliary excretion of ceftriaxone. Eur J Clin Pharmacol 31:123–124

    Article  PubMed  CAS  Google Scholar 

  9. Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D ,Peterson PK (1990) Apparent biliary pseudolithiasis during ceftriaxone therapy. Antimicrob Agents Chemother 34:1146–1149

    PubMed  CAS  Google Scholar 

  10. Herek O, Pakdemirli E ,Kocer N (2001) Ceftriaxone-associated biliary pseudolithiasis in children. Eur Radiol 11:902

    Article  PubMed  CAS  Google Scholar 

  11. Jacobs RF (1988) Ceftriaxone-associated cholecystitis. Pediatr Infect Dis J 7:434–436

    PubMed  CAS  Google Scholar 

  12. Kearney DK ,O’Donnell D (1998) Iatrogenic gallstones: a ceftriaxone complication. Australas Radiol 42:236–237

    Article  PubMed  CAS  Google Scholar 

  13. Kirejczyk WM, Crowe HM, Mackay IM, Quintiliani R ,Cronin EB (1992) Disappearing “gallstones”: biliary pseudolithiasis complicating ceftriaxone therapy. AJR Am J Roentgenol 159:329–330

    PubMed  CAS  Google Scholar 

  14. Lemberg D, Day AS ,Wyeth B (2005) Biliary colic: Is it gallstones? J Paediatr Child Health 41:291–293

    Article  PubMed  Google Scholar 

  15. Lopez AJ, O’Keefe P, Morrissey M ,Pickleman J (1991) Ceftriaxone-induced cholelithiasis. Ann Intern Med 115:712–714

    PubMed  CAS  Google Scholar 

  16. Maranan MC, Gerber SI ,Miller GG (1998) Gallstone pancreatitis caused by ceftriaxone. Pediatr Infect Dis J 17:662–663

    Article  PubMed  CAS  Google Scholar 

  17. McNamara PJ, Stoeckel K ,Ziegler WH (1982) Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. Eur J Clin Pharmacol 22:71–75

    Article  PubMed  CAS  Google Scholar 

  18. Meyboom RH, Kuiper H ,Jansen A (1988) Ceftriaxone and reversible cholelithiasis. Bmj 297:858

    Article  PubMed  CAS  Google Scholar 

  19. Palanduz A, Yalcin I, Tonguc E, Guler N, Ones U, Salman N, Somer A (2000) Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound 28:166–168

    Article  PubMed  CAS  Google Scholar 

  20. Papadopoulou F, Efremidis S, Karyda S, Badouraki M, Karatza E, Panteliadis C, Malaka K (1999) Incidence of ceftriaxone-associated gallbladder pseudolithiasis. Acta Paediatr 88:1352–1355

    Article  PubMed  CAS  Google Scholar 

  21. Park HZ, Lee SP ,Schy AL (1991) Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 100:1665–1670

    PubMed  CAS  Google Scholar 

  22. Patel IH ,Kaplan SA (1984) Pharmacokinetic profile of ceftriaxone in man. Am J Med 77:17–25

    PubMed  CAS  Google Scholar 

  23. Pigrau C, Pahissa A, Gropper S, Sureda D ,Martinez Vazquez JM (1989) Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 2:165

    Article  PubMed  CAS  Google Scholar 

  24. Prince JS ,Senac MO Jr (2003) Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child. Pediatr Radiol 33:648–651

    Article  PubMed  Google Scholar 

  25. Richards DM, Heel RC, Brogden RN, Speight TM ,Avery GS (1984) Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 27:469–527

    Article  PubMed  CAS  Google Scholar 

  26. Robertson FM, Crombleholme TM, Barlow SE, Verhave M ,Brown D (1996) Ceftriaxone choledocholithiasis. Pediatrics 98:133–135

    PubMed  CAS  Google Scholar 

  27. Schaad UB, Tschappeler H ,Lentze MJ (1986) Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis 5:708–710

    Article  PubMed  CAS  Google Scholar 

  28. Schaad UB, Wedgwood-Krucko J ,Tschaeppeler H (1988) Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 2:1411–1413

    Article  PubMed  CAS  Google Scholar 

  29. Shiffman ML, Keith FB ,Moore EW (1990) Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 99:1772–1778

    PubMed  CAS  Google Scholar 

  30. Stabile A, Ferrara P, Marietti G ,Maresca G (1995) Ceftriaxone-associated gallbladder lithiasis in children. Eur J Pediatr 154:590

    Article  PubMed  CAS  Google Scholar 

  31. Xia Y, Lambert KJ, Schteingart CD, Gu JJ ,Hofmann AF (1990) Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology 99:454–465

    PubMed  CAS  Google Scholar 

  32. Zinberg J, Chernaik R, Coman E, Rosenblatt R ,Brandt LJ (1991) Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. Am J Gastroenterol 86:1251–1254

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery and Vascular Biology, Children’s Hospital Boston, Fegan 3, 300 Longwood Avenue, Boston, MA, 02115, USA

    Sendia Kim, Kathleen M. Gura & Mark Puder

Authors
  1. Sendia Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathleen M. Gura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Puder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Puder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S., Gura, K.M. & Puder, M. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis. Ped Surgery Int 22, 562–564 (2006). https://doi.org/10.1007/s00383-006-1656-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-006-1656-1

Keywords

Search

Navigation